Quanterix CEO Discusses the Advantages of Monitoring Both Health and Disease in the Human Body

SelectScience
|

Kevin Hrusovsky is President and CEO of Quanterix, a company that is developing an ultrasensitive immunoassay platform that is capable of detecting very low levels of biomarkers in the body. Watch this exclusive interview to discover Hrusovsky’s vision for the future of healthcare. 

Visit SelectScience.com to watch the entire video.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more